Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma

被引:0
作者
Liguo Lin
Kaihua Zhong
Zhongkai Sun
Guozhong Wu
Guodong Ding
机构
[1] Meizhou Affiliated Hospital of Sun Yat-sen University,Department of Urinary Surgery, MeiZhou People’s Hospital
来源
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词
Receptor for advanced glycation end products (RAGE); High-mobility group box-1 (HMGB1); Signal transduction; Proliferation; Metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 22
页数:11
相关论文
共 291 条
[1]  
Arumugam T(2006)Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models J Natl Cancer Inst 98 1806-1818
[2]  
Ramachandran V(2010)Current management of advanced and metastatic renal cell carcinoma Urol J 7 1-9
[3]  
Logsdon CD(2010)Cardiovascular disease: what’s all the AGE/RAGE about? Cardiovasc Hematol Disord Drug Targets 10 7-15
[4]  
Ather MH(2008)HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration J Neurooncol 87 23-33
[5]  
Masood N(2008)The alternative NF-kB activation pathway and cancer: friend or foe? Med Sci (Paris) 24 1083-1088
[6]  
Siddiqui T(2011)S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release J Biol Chem 286 7214-7226
[7]  
Barlovic DP(2009)Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications Diabetologia 52 2251-2263
[8]  
Thomas MC(2003)HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma Faseb J 17 1295-1297
[9]  
Jandeleit-Dahm K(2009)Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer J Transl Med 7 38-2916
[10]  
Bassi R(2004)Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation Circulation 109 2911-336